UnknownPhase 2NCT00474435

Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Tuberculosis

Studying Primary genito-urinary tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
African Poverty Related Infection Oriented Research Initiative
Principal Investigator
Martin Boeree, MD, PhD
University Lungcentre Dekkerswald, Groesbeek / University Medical Centre Nijmegen, the Netherlands
Intervention
Emtricitabine/tenofovir/efavirenz(drug)
Enrollment
30 enrolled
Eligibility
18-65 years · All sexes
Timeline
2008 – 2009

Study locations (1)

Collaborators

Radboud University Medical Center · Kilimanjaro Christian Medical Centre, Tanzania

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00474435 on ClinicalTrials.gov

Other trials for Primary genito-urinary tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Primary genito-urinary tuberculosis →

← Back to all trials